Meet Lisly Chery, M.D.
Lisly Chery
Department of Urology, Division of Surgery
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2009 | Albert Einstein College of Medicine, Bronx, NY, USA, MD, Medicine |
| 2003 | Princeton University, New Jersey, NJ, USA, BA, Molecular Biology |
Postgraduate Training
| 2015-2017 | Clinical Fellowship, Urologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2014-2015 | Chief Residency, University of Washington, Seattle, WA |
| 2010-2014 | Clinical Residency, Urology, University of Washington, Seattle, WA |
| 2009-2010 | Clinical Internship, General Surgery, University of Washington, Seattle, WA |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Chéry L, Borregales LD, Fellman B, Urbauer DL, Garg N, Parker N, Katz MHG, Wood CG, Karam JA. The Effects of Neoadjuvant Axitinib on Anthropometric Parameters in Patients With Locally Advanced Non-metastatic Renal Cell Carcinoma. Urology 108:114-121, 2017. e-Pub 2017. PMID: 28705573.
- Chery LJ, Karam JA, Wood CG. Cytoreductive nephrectomy for metastatic renal cell carcinoma. Clin Adv Hematol Oncol 14(9):696-703, 2016. PMID: 27673288.
- Roudier MP, Winters BR, Coleman I, Lam HM, Zhang X, Coleman R, Chéry L, True LD, Higano CS, Montgomery B, Lange PH, Snyder LA, Srivastava S, Corey E, Vessella RL, Nelson PS, Üren A, Morrissey C. Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer. Prostate 76(9):810-22, 2016. e-Pub 2016. PMID: 26990456.
- Wright JL, Chéry L, Holt S, Lin DW, Luedeke M, Rinckleb AE, Maier C, Stanford JL. Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status. Prostate Cancer Prostatic Dis 19(1):53-6, 2016. e-Pub 2015. PMID: 26503111.
- Zhang X, Coleman IM, Brown LG, True LD, Kollath L, Lucas JM, Lam HM, Dumpit R, Corey E, Chéry L, Lakely B, Higano CS, Montgomery B, Roudier M, Lange PH, Nelson PS, Vessella RL, Morrissey C. SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer. Clin Cancer Res 21(20):4698-708, 2015. e-Pub 2015. PMID: 26071481.
- Chéry L, Dash A. The Role of Postchemotherapy Surgery in Germ Cell Tumors. Urol Clin North Am 42(3):331-42, 2015. e-Pub 2015. PMID: 26216820.
- Macleod LC, Chery LJ, Hu EY, Zeliadt SB, Holt SK, Lin DW, Porter MP, Gore JL, Wright JL. Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort. Prostate Cancer Prostatic Dis 18(2):190-5, 2015. e-Pub 2015. PMID: 25823651.
- Chéry L, Lam HM, Coleman I, Lakely B, Coleman R, Larson S, Aguirre-Ghiso JA, Xia J, Gulati R, Nelson PS, Montgomery B, Lange P, Snyder LA, Vessella RL, Morrissey C. Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways. Oncotarget 5(20):9939-51, 2014. PMID: 25301725.
- Cheng HH, Mitchell PS, Kroh EM, Dowell AE, Chéry L, Siddiqui J, Nelson PS, Vessella RL, Knudsen BS, Chinnaiyan AM, Pienta KJ, Morrissey C, Tewari M. Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia. PLoS One 8(7):e69239, 2013. e-Pub 2013. PMID: 23935962.
- Hakimi AA, Rajpathak S, Chery L, Shapiro E, Ghavamian R. Renal insufficiency is an independent risk factor for complications after partial nephrectomy. J Urol 183(1):43-7, 2010. PMID: 19913240.
Patient Reviews
CV information above last modified April 19, 2018